Beneficial effects of integrin αvβ3-blocking RGD peptides in early but not late phase of experimental glomerulonephritis.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Volumn 27, Issue 5, 2012, Pages 1755-1768

  Amann, Kerstin ^a   Haas, Christian S ^b   Schüssler, Julian ^b   Daniel, Christoph ^b   Hartner, Andrea ^b   Schöcklmann, Harald O ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARGINYL-GLYCYL-ASPARTIC ACID; ARGINYLGLYCYLASPARTIC ACID; CREATININE; OLIGOPEPTIDE; SNAKE VENOM; VITRONECTIN RECEPTOR;

ANIMAL; APOPTOSIS; ARTICLE; BLOOD; C57BL MOUSE; CELL CULTURE; CELL PROLIFERATION; DISEASE MODEL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; GLOMERULONEPHRITIS; IN VITRO STUDY; MALE; MESANGIUM CELL; MOUSE; PATHOLOGY; TIME;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; CREATININE; CROTALID VENOMS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLOMERULONEPHRITIS; INTEGRIN ALPHAVBETA3; MALE; MESANGIAL CELLS; MICE; MICE, INBRED C57BL; OLIGOPEPTIDES; TIME FACTORS;

EID: 84868340975     PISSN: None     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr603     Document Type: Article

References (0)